BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20845611)

  • 21. Current management of primary central nervous system lymphoma.
    Schultz CJ; Bovi J
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):666-78. PubMed ID: 20159361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-grade primary central nervous system lymphoma in immunocompetent patients.
    Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
    Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of primary central nervous system lymphoma.
    Ekenel M; DeAngelis LM
    Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and management of primary CNS lymphoma.
    Roth P; Korfel A; Martus P; Weller M
    Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary central nervous system lymphoma--a single center experience].
    Mitrović Z; Radman I; Aurer I; Petranović D; Santek F; Labar B
    Lijec Vjesn; 2007 Dec; 129(12):391-5. PubMed ID: 18383741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome?
    Schaller C; Kelly PJ
    Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary central nervous system lymphoma.
    Freilich RJ; DeAngelis LM
    Neurol Clin; 1995 Nov; 13(4):901-14. PubMed ID: 8584003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New treatment approaches in primary central nervous system lymphoma.
    Soussain C; Hoang-Xuan K; Doolittle ND
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):719-28, vii. PubMed ID: 16083832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
    Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
    Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
    Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
    Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
    Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
    Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [T-type primary lymphoma of the central nervous system in immunocompetent patients].
    Barrena-Caballo MR; Blanch-Labrador M; Giménez-Mas JA; Alberdi-Viñas J; Pascual-Piazuelo M; Zubiri-Ara L
    Rev Neurol; 2003 Jan 16-31; 36(2):125-30. PubMed ID: 12589598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary central nervous system lymphoma.
    Ferreri AJ; Reni M
    Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary CNS lymphoma.
    Maher EA; Fine HA
    Semin Oncol; 1999 Jun; 26(3):346-56. PubMed ID: 10375091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary lymphoma of the central nervous system.
    Singh AD; Lewis H; Schachat AP
    Ophthalmol Clin North Am; 2005 Mar; 18(1):199-207, x. PubMed ID: 15763205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
    Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.